Vaccine developers hustle to meet FDA data requirements to submit for approval
5 years ago 1 min read
There are many questions about a potential COVID-19 development, including a lack of diversity among volunteers, and a rushed approval in a politicized atmosphere.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push